Piramal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
2,302.86
1,970.68
2,578.74
2,020.08
1,960.57
Other Income Qtr Cr61.1119.5426.3861.5149.19
Operating Revenues Qtr2,241.751,951.142,552.361,958.571,911.38

*All values are in Cr.

Operating Expenses Qtr
1,900.14
1,746.65
2,022.43
1,690.20
1,645.74
Operating Profit Qtr
341.61
204.49
529.93
268.37
265.64
EBIDT Qtr Cr
402.72
224.03
525.79
297.61
314.83
Depreciation Qtr
192.22
184.55
196.13
186.32
184.51
Net Profit Qtr
22.59
-88.64
101.27
10.11
5.02
Basic EPS Qtr
0.17
-0.67
0.77
0.08
0.04
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -